Literature DB >> 30969507

Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.

Sebastian Rauer1, Reinhard Marks1, Horst Urbach1, Klaus Warnatz1, Avindra Nath2, Steve Holland2, Cornelius Weiller3, Bodo Grimbacher3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30969507     DOI： 10.1056/NEJMc1817193

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.

Authors:  Aabha Oza; Michael P Rettig; Phil Powell; Kathryn O'Brien; David B Clifford; Julie Ritchey; Leah Gehrs; Julia Hollaway; Eugene Major; Todd A Fehniger; Christopher A Miller; Patrick Soon-Shiong; Amy Rock; John F DiPersio
Journal:  Blood Adv       Date:  2020-06-09

2.  PD-1 inhibition: a novel approach to the treatment of progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Ann Transl Med       Date:  2019-12

3.  Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

Authors:  Daniele Focosi; Marco Tuccori; Fabrizio Maggi
Journal:  Ann Transl Med       Date:  2019-12

Review 4.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

5.  Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy.

Authors:  Julien Haroche; Fleur Cohen Aubart; Karima Mokhtari; Danielle Seilhean; Neila Benameur; Matthieu Peyre; Ahmed Idbaih; Zahir Amoura
Journal:  Neurol Clin Pract       Date:  2021-06

Review 6.  Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.

Authors:  Sydney Corey; Bryan R Smith; Irene C M Cortese
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-01       Impact factor: 5.495

7.  PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy.

Authors:  Nora Möhn; Mike P Wattjes; Ortwin Adams; Sandra Nay; Daria Tkachenko; Friederike Salge; Johanne Heine; Kaweh Pars; Günter Höglinger; Gesine Respondek; Martin Stangel; Thomas Skripuletz; Roland Jacobs; Kurt-Wolfram Sühs
Journal:  Ther Adv Neurol Disord       Date:  2021-03-09       Impact factor: 6.570

Review 8.  Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration.

Authors:  S Richard Dunham; Robert Schmidt; David B Clifford
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

9.  Combined Treatment With Pembrolizumab and Allogenic BK Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Case Report.

Authors:  Rebecca Wicklein; Simon Heidegger; Mareike Verbeek; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Jan Stefan Kirschke; Agata Page; Thomas Korn; Bernhard Hemmer; Marcus Deschauer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-20

Review 10.  Virus-specific T-cell therapies for patients with primary immune deficiency.

Authors:  Michael D Keller; Catherine M Bollard
Journal:  Blood       Date:  2020-02-27       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.